- Home
- BBCP vs ENGN Comparison
BBCP vs ENGN Comparison
Compare BBCP & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBCP | ENGN |
|---|---|---|
| Founded | 1983 | 1999 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 333.0M | 379.3M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | BBCP | ENGN |
|---|---|---|
| Price | $7.00 | $8.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | $7.50 | ★ $22.71 |
| AVG Volume (30 Days) | 105.4K | ★ 314.7K |
| Earning Date | 01-07-2026 | 12-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $395,562,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.28 | N/A |
| P/E Ratio | $42.98 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.78 | $2.65 |
| 52 Week High | $9.68 | $11.14 |
Technical Indicators
Market Signals| Indicator | BBCP | ENGN |
|---|---|---|
| Relative Strength Index (RSI) | 60.60 | 56.36 |
| Support Level | $6.76 | $7.57 |
| Resistance Level | $7.18 | $8.47 |
| Average True Range (ATR) | 0.32 | 0.64 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 80.36 | 63.69 |
Price Performance
Historical ComparisonAbout BBCP Concrete Pumping Holdings Inc.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.